Blastocyst Biopsy, PGT Testing & IVF Laboratory Workflow — How Clinics Evaluate Day-5/Day-6 Embryos

AI SMART SUMMARY

A blastocyst biopsy is a laboratory procedure performed at licensed fertility clinics to remove a small sample of trophectoderm (TE) cells for optional genetic testing, such as PGT-A. This procedure is typically performed when the embryo reaches the blastocyst stage on Day-5 or Day-6.

The biopsy does not involve the inner cell mass (ICM), which develops into the fetus. All embryology and medical procedures are conducted exclusively by licensed fertility clinics. EggDonors4All provides education and coordination support only.

Key Points:

• Sample taken from trophectoderm (TE), not inner cell mass (ICM)
• Enables optional PGT-A genetic testing
• Performed by trained embryologists in IVF laboratories
• Used for embryo assessment before freezing or transfer
• EggDonors4All provides education only

During IVF treatment, intended parents may hear terms like blastocyst biopsy, PGT testing, or Day-5 embryo evaluation. However, the laboratory steps behind these processes are not always clearly explained.

This guide provides a clear, non-medical overview of how embryos are evaluated at the blastocyst stage.

EggDonors4All offers education and donor-cycle coordination. All embryology procedures—including biopsy and genetic testing—are performed exclusively by licensed fertility clinics.

What Is a Blastocyst Biopsy? 

A blastocyst biopsy involves removing a small number of trophectoderm (TE) cells from a Day-5 or Day-6 embryo.

Purpose

To allow optional genetic testing (PGT-A or other screening panels) before the embryo is frozen or transferred.

Important Notes

• The inner cell mass (ICM), which becomes the fetus, is not biopsied.
• The removed TE cells often regenerate.
• The procedure is performed under strict laboratory standards.

Why Is Biopsy Performed at the Blastocyst Stage?

By Day-5 or Day-6, embryos typically have:

• 100–200+ cells
• Distinct layers (ICM and TE)
• A stable structure suitable for sampling
• A visible fluid cavity (blastocoel)

Sampling TE cells at this stage is preferred because:

• TE cells develop into the placenta
• Removing a few TE cells avoids disturbing the ICM
• A higher cell number improves testing reliability

Step-by-Step Laboratory Workflow for Blastocyst Biopsy

1. Embryo Reaches Blastocyst Stage: Embryologists evaluate expansion, ICM quality, and TE structure.
2. Embryo Positioning: The embryo is stabilized under a specialized microscope.
3. Opening the Zona Pellucida: A small opening is typically created using a precision laser system.
4. Trophectoderm Sampling: A few TE cells are gently removed using micromanipulation tools.
5. Cell Preparation for Testing: The sampled cells are placed into a testing medium and sent to a genetic laboratory.
6. Embryo Freezing (Vitrification): Most biopsied embryos are frozen and stored until test results are available.

What Is PGT-A and Why Is It Performed?

PGT-A (Preimplantation Genetic Testing for Aneuploidy) screens embryos for chromosomal differences.

Families may choose PGT-A to:

• Gain additional information before transfer
• Reduce the risk of transferring chromosomally abnormal embryos
• Meet certain surrogacy program requirements
• Support informed family-planning decisions

Important Clarification: PGT-A is optional. Each fertility clinic provides individualized medical guidance. EggDonors4All does not perform or interpret genetic testing.

Does a Blastocyst Biopsy Harm the Embryo?

Embryologists are trained to remove only trophectoderm cells, which:

• Do not form the fetus
• Can regenerate
• Are structurally appropriate for genetic testing

Biopsied embryos—particularly in frozen transfer cycles—continue to show strong clinical outcomes under proper laboratory conditions.

How Do Clinics Decide Which Embryos to Biopsy?

Biopsy recommendations may depend on:

• Intended parents’ preferences
• Medical and reproductive history
• Genetic counseling input
• Number of available blastocysts
• Surrogacy or international IVF requirements

Not all embryos are biopsied.

Blastocyst Biopsy in Donor-Egg IVF

Donor-egg embryos often reach the blastocyst stage in higher numbers, providing families with:

• More embryos potentially eligible for biopsy
• Expanded options for long-term family planning
• Greater flexibility for surrogacy timelines

Embryo testing remains optional and guided by the fertility clinic.

Common Questions About Blastocyst Biopsy

Q. Does biopsy remove cells from the future fetus?

Ans. No. The inner cell mass (ICM) is not biopsied.

Q. Do all clinics perform biopsy the same way?

Ans. Protocols may vary slightly, but clinics follow established laboratory standards.

Q. Can Day-6 blastocysts be biopsied?

Ans. Yes. Many clinics biopsy Day-6 embryos.

Q. Does biopsy guarantee pregnancy?

Ans. No. Genetic testing provides information, not pregnancy guarantees.

Q. Can biopsy be performed on Day-3 embryos?

Ans. Rarely. The blastocyst stage is generally preferred for accuracy and safety.

Guaranteed Blastocysts 

Families may choose structured outcome programs for:

• Reduced uncertainty early in IVF
• Clarity before transfer decisions
• Improved surrogacy coordination
• More predictable IVF planning

EggDonors4All coordinates these programs. All biopsy procedures and laboratory work are performed by licensed fertility clinics.

Need clarity on biopsy, genetic testing, or embryo development?

EggDonors4All provides donor matching, structured embryo-outcome programs, and transparent educational support—while licensed fertility clinics perform all medical and laboratory procedures.

• Explore Guaranteed Blastocysts
• Request Donor Information
• Become an Egg Donor